BioManufacturing: Expanding Production Capacity in Emerging Regions
Date & Time:
8th Dec 2021
10:00am WedAdd to calendar
GenevaView on maps
Biologics, a category of pharmaceuticals which includes products such as vaccines and monoclonal antibody treatments, are quickly becoming among the most important medical products in the world. By combining enabling government policies and technology transfer between innovators and their global partners, it will be possible to improve availability of biologics, increase health security, and enhance scientific and industrial capacity in developing countries. Africa is primed for these types of investments as evidenced by the new multi-stakeholder initiative to establish mRNA manufacturing on the continent.